Akums Drugs and Pharmaceuticals is a company specializing in pharmaceutical contract development and manufacturing offering an array of products and services both, in India and internationally. Being a player in the CDMO industry in India Akums possesses the rights to the production methods of formulations with a key emphasis, on delivering complete product development and manufacturing services to its clients.
They offer services such, as conducting research and development (R&D) preparing and submitting documents for markets in India and globally, and providing a range of testing services. Apart from their business, as a CDMO Akums is also involved in producing and selling pharmaceutical formulations under their brand name as well as active pharmaceutical ingredients (APIs).
They create a variety of medication forms, such, as tablets, capsules, liquid medicines, vials, ampoules, topical treatments, eye drops, powder injections, and gummy supplements.
Akums nurtures bonds, with its clients, known for their dedication to reliability and mutual trust. Some prominent clients in their CDMO business include Alembic Pharmaceuticals, Alkem Laboratories, Blue Cross Laboratories, Cipla, Dabur India, Dr. Reddy’s Laboratories, Hetero Healthcare, Ipca Laboratories, Mankind Pharma, MedPlus Health Services, Micro Labs, Mylan Pharmaceuticals, Natco Pharma Sun Pharmaceutical Industries, UCB and Amishi Consumer Technologies, among others.
Akums Drugs and Pharmaceuticals IPO Complete Details:
Akums Drugs and Pharmaceuticals IPO Timetable:
Company Financial Details:
AS OF NOW, the GMP Of Akums Drugs and Pharmaceuticals is Around 190 Rs.
Objects Of Issue:
a. Repaying or prepaying the indebtedness of our Company and its subsidiaries.
b. Funding the incremental working capital requirements of our Company.
c. Pursuing inorganic growth initiatives through acquisitions.
d. Supporting general corporate purposes.
Promoters:
- SANJEEV JAIN
- SANDEEP JAIN
- AKUMS MASTER TRUST
FAQs:
When Akums Drugs and Pharmaceuticals IPO is Opening?
Akums Drugs and Pharmaceuticals IPO is Opening on 30 July 2024.
When is the Akums Drugs and Pharmaceuticals IPO Closing?
Akums Drugs and Pharmaceuticals IPO is Closing on 01 August 2024.
What is the Issue Size of the Akums Drugs and Pharmaceuticals IPO?
The IPO Issue Size of Akums Drugs and Pharmaceuticals is 1,856.74 Crore.
Price Band of Akums Drugs and Pharmaceuticals IPO?
The price Band of the Akums Drugs and Pharmaceuticals IPO is 646 to 679 rupees per share.
What is the minimum investment for Akums Drugs and Pharmaceuticals IPO?
The minimum investment for the Akums Drugs and Pharmaceuticals IPO is 14,938 rupees.
Allotment Date of Akums Drugs and Pharmaceuticals IPO?
The Allotment of Akums Drugs and Pharmaceuticals IPO is on 02 August 2024.
Listing Date of Akums Drugs and Pharmaceuticals IPO?
The Listing Of Akums Drugs and Pharmaceuticals is Scheduled on 06 August 2024.
One Should Apply for Akums Drugs and Pharmaceuticals IPO or Not?
Will Update Soon..
Who is the Lead Manager of Akums Drugs and Pharmaceuticals?
ICICI Securities Limited, Axis Bank Limited, Citigroup Global Markets India Private Limited, and Ambit Private Limited are the Lead Managers of Akums Drugs and Pharmaceuticals.
Where To Check the Allotment of Akums Drugs and Pharmaceuticals IPO?
The allotment status for the Akums Drugs and Pharmaceuticals IPO will be accessible on the Link Intime India Private Ltd Website.
Akums Drugs and Pharmaceuticals IPO is going to be listed at?
Akums Drugs and Pharmaceuticals IPO is going to be listed at NSE and BSE.
What is the Lot Size of the Akums Drugs and Pharmaceuticals IPO?
The lot size of the Akums Drugs and Pharmaceuticals IPO is 22 Shares.
What is the P/E Ratio of Akums Drugs and Pharmaceuticals?
The P/E Ratio of the Akums Drugs and Pharmaceuticals is N/A.
What is the EPS of the Akums Drugs and Pharmaceuticals?
The EPS of Akums Drugs and Pharmaceuticals is N/A.
What is the ROE of the Akums Drugs and Pharmaceuticals?
The ROE of Akums Drugs and Pharmaceuticals is 0.11%.
What is the ROCE of the Akums Drugs and Pharmaceuticals?
The ROCE of Akums Drugs and Pharmaceuticals is 3.37%.